Improvest is a drug owned by ZOETIS INC. It is protected by 1 US drug patent filed in 2019. All patents have expired. Details of Improvest’s patents and their expiration are given below.
| Drug Patent Number | Drug Patent Expiry | Status |
|---|---|---|
 | ||
| US7534441 | Active | |
Exclusivity Information
Improvest holds 1 exclusivity out of which 1 has expired. Details of Improvest's exclusivity codes and their expiration dates are given below.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| NCI | Mar 27, 2023 |
About Improvest
Improvest is a drug
owned by ZOETIS INC.
Improvest uses
Gonadotropin Releasing Factor – Diphtheria Toxoid Conjugate as the active
ingredient.
Active Ingredient:
Improvest uses
Gonadotropin Releasing Factor – Diphtheria Toxoid Conjugate as the active ingredient.
Check out other Drugs and Companies using
Gonadotropin Releasing Factor – Diphtheria Toxoid Conjugate ingredient.